The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Non-tuberculous mycobacterial pulmonary disease
Open accessAbstract
Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection which is becoming increasingly prevalent, particularly in the elderly, for reasons which are unknown. While underlying lung disease is a well-established risk factor for NTM-PD, it may also occur in apparently healthy individuals. No single common genetic or immunological defect has been identified in this group, and it is likely that multiple pathways contribute towards host susceptibility to NTM-PD which further interact with environmental and microbiological factors leading to the development of disease. The diagnosis of NTM-PD relies on the integration of clinical, radiological and microbiological results. The clinical course of NTM-PD is heterogeneous, with some patients remaining stable without the need for treatment and others developing refractory disease associated with considerable mortality and morbidity. Treatment regimens are based on the identity of the isolated species, drug sensitivity testing (for some agents) and the severity of disease. Multiple antibiotics are typically required for prolonged periods of time and treatment is frequently poorly tolerated. Surgery may be beneficial in selected cases. In some circumstances cure may not be attainable and there is a pressing need for better regimens to treat refractory and drug-resistant NTM-PD. This review summarises current knowledge on the epidemiology, aetiology and diagnosis of NTM-PD and discusses the treatment of two of the most clinically significant species, the M. avium and M. abscessus complexes, with a focus on refractory disease and novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–215 of 215
Wu, T., Chia, J., Kuo, A.-J., Su, L., Wu, T., & Lai, H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00856-08 · Cited by 36
Chen, F., Szymanski, E. P., Olivier, K. N., Liu, X., Tettelin, H., Holland, S. M., & Duggal, P. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201612-2479oc · Cited by 36
Serodiagnosis ofMycobacterium abscessuscomplex infection in cystic fibrosis
Qvist, T., Pressler, T., Taylor-Robinson, D. C., Katzenstein, T. L., & Høiby, N. (2015) · European Respiratory Journal · doi:10.1183/09031936.00011815 · Cited by 35
Mefloquine as a potential drug against multidrug-resistant tuberculosis
Krieger, D., Vesenbeckh, S. M., Schönfeld, N., Bettermann, G., Bauer, T. T., Rüssmann, H., & Mauch, H. (2015) · European Respiratory Journal · doi:10.1183/13993003.00321-2015 · Cited by 33
Toll-Like Receptor 2 Polymorphisms and Nontuberculous Mycobacterial Lung Diseases
Ryu, Y. J., Kim, E. J., Koh, W., Kim, H., Kwon, O. J., & Chang, J. H. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00025-06 · Cited by 31
Shu, C., Ato, M., Wang, J., Jou, R., Wang, J.-Y., Kobayashi, K., Lai, H., Yu, C., Lee, L., & Luh, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080473 · Cited by 30
Sharp, S. E., Lemes, M., Sierra, S. G., Poniecka, A. W., & Poppiti, R. (2000) · American Journal of Clinical Pathology · doi:10.1309/jhdd-1hf4-2kcn-7anp · Cited by 30
The wobbly status of ketolides: where do we stand?
Georgopapadakou, N. H. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954036 · Cited by 26
Lutzky, V. P., Ratnatunga, C. N., Smith, D. B., Kupz, A., Doolan, D. L., Reid, D. W., Thomson, R. M., Bell, S. C., & Miles, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01319 · Cited by 26
Shu, C., Wang, J., Wu, M., Lai, H., Chiang, B., & Yu, C. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.03.001 · Cited by 19
Diagnosis of Nontuberculous Mycobacteria Lung Disease
Cowman, S. A., & Loebinger, M. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1651493 · Cited by 18
Self-citationDeficient interleukin-17 production in response toMycobacterium abscessusin cystic fibrosis
Becker, K. L., van Ingen, J., ten Oever, J., Merkus, P. J. F. M., Ferwerda, G., Netea, M. G., Magis-Escurra, C., Reijers, M. H. E., & van de Veerdonk, F. L. (2016) · European Respiratory Journal · doi:10.1183/13993003.00446-2015 · Cited by 17
Farnia, P., Ghanavi, J., Saif, S., Farnia, P., & Velayati, A. A. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0905 · Cited by 15
Affandi, J. S., Hendry, S. A., WATERER, G. W., Thomson, R. M., Wallace, H. J., Burrows, S., & Price, P. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.06.019 · Cited by 12
Interleukin-12 Receptor β1 Polymorphisms and Nontuberculous Mycobacterial Lung Diseases
Park, H. Y., Kwon, Y. S., Ki, C., Suh, G. Y., Chung, M. P., Kim, H., Kwon, O. J., & Koh, W. (2008) · Lung · doi:10.1007/s00408-008-9096-4 · Cited by 12
Cited by
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
Dahl, V. N., Mølhave, M., Fløe, A., van Ingen, J., Schön, T., Lillebaek, T., Andersen, A. B., & Wejse, C. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.013 · Cited by 329
Self-citation
Metadata
- Authors
- Cowman, S., van Ingen, J., Griffith, D. E., & Loebinger, M. R.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-06-20
- Volume
- 54
- Issue
- 1
- Pages
- 1900250
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2557635410
- Cited by
- 302
- References
- 215
- FWCI
- 19.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.